Clinical validation of the AGE Reader technology to reliably, easily and quickly assess risk for CVD and diabetes grabs international attention.
https://t.co/MXP6IziCtZ
Skin autofluorescence predicts major adverse cardiovascular events in patients with type 1 diabetes: a 7-year follow-up study. https://t.co/lMIHL8Jp03
Interested in more studies on Skin Autofluorescence? --> https://t.co/OIYQUrb0jx
Accumulation of Advanced Glycation Endproducts and Subclinical Inflammation in Deep Tissues of Adult Patients With and Without Diabetes. https://t.co/grXDM11lsl
Skin autofluorescence, a non-invasive biomarker for advanced glycation end products, is not related to the number of pregnancies. https://t.co/7Tp0Kmbcaa
Interesting video from @NTUsg about Advanced Glycation Endproducts and their links to degenerative and lifestyle-related diseases: https://t.co/BF1kiEXISN
De wereld verbeteren en veroveren met een medisch product, hoe doe je dat? ontmoet Bart van de Berg CEO van @DiagnOptics. 22 Mei @groningerforum Haal je kaartje nu! => https://t.co/26y0HnH8lF
Relationship between advanced glycation end-product accumulation in the skin and pulmonary function. Full text version: https://t.co/i0cDlqQg1o #AGEReader
Association Between Self-reported Physical Activity and Skin Autofluorescence, a Marker of Tissue Accumulation of Advanced Glycation End Products in Adults With Type 1 Diabetes: A Cross-sectional Study. https://t.co/hAbXwKwXp9